C9479 – Instillation, ciprofloxacin otic suspension, 6 mg
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9479
- Long description
- Instillation, ciprofloxacin otic suspension, 6 mg
- Short description
- Instill, ciprofloxacin otic
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Cross reference
- J7342
- Added
- July 1, 2016
- Last change
- January 1, 2017 – No change
- Termination date
- December 31, 2016
Frequently asked questions
What is HCPCS code C9479?
C9479 is a HCPCS Level II code for instillation, ciprofloxacin otic suspension, 6 mg. It was discontinued on December 31, 2016.
Does Medicare cover C9479?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9471 – Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
- C9472 – Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)
- C9473 – Injection, mepolizumab, 1 mg
- C9474 – Injection, irinotecan liposome, 1 mg
- C9475 – Injection, necitumumab, 1 mg
- C9476 – Injection, daratumumab, 10 mg
- C9477 – Injection, elotuzumab, 1 mg
- C9478 – Injection, sebelipase alfa, 1 mg
- C9480 – Injection, trabectedin, 0.1 mg
- C9481 – Injection, reslizumab, 1 mg
- C9482 – Injection, sotalol hydrochloride, 1 mg
- C9483 – Injection, atezolizumab, 10 mg
- C9484 – Injection, eteplirsen, 10 mg
- C9485 – Injection, olaratumab, 10 mg
- C9486 – Injection, granisetron extended release, 0.1 mg
- C9487 – Ustekinumab, for intravenous injection, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.